Viewing data from:

CELECOXIB

ANDA

CELECOXIB | A202240 | LUPIN LTD

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CELEBREX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.0883

per ea

Lowest NADAC/Unit

$0.0621

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68180039507CELECOXIB 50 MG CAPSULE	$0.0883	EA	Generic	—	2026-08-19
68180039901CELECOXIB 200 MG CAPSULE	$0.0760	EA	Generic	—	2026-08-19
68180039601CELECOXIB 100 MG CAPSULE	$0.0621	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain27 active DMFs4 inactive

26 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDCELECOXIB USP

DMF 166712003

MATRIX PHARMACORP PRIVATE LTDCELECOXIB USP

DMF 176972004

CADILA PHARMACEUTICALS LTDCELECOXIB USP

DMF 191552006

DR REDDYS LABORATORIES LTDCELECOXIB USP

DMF 219212008

AARTI DRUGS LTDCELECOXIB

DMF 231612009

LUPIN LTDCELECOXIB USP

DMF 235432010

ALEMBIC PHARMACEUTICALS LTDCELECOXIB USP

DMF 244192010

HETERO DRUGS LTDCELECOXIB

DMF 245572011

MICRO LABS LTDCELECOXIB USP

DMF 246862010

AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)CELECOXIB USP

DMF 254272012

JIANGXI SYNERGY PHARMACEUTICAL CO LTDCELECOXIB

DMF 255822011

RAKS PHARMA PVT LTDCELECOXIB, USP

DMF 256362011

MACLEODS PHARMACEUTICALS LTDCELECOXIB

DMF 257922012

PHARMAZELL INDIA PRIVATE LTDCELECOXIB USP

DMF 263562012

INTERQUIM SACELECOXIB

DMF 268862013

SAURAV CHEMICALS LTDCELECOXIB USP

DMF 273842015

APITORIA PHARMA PRIVATE LTDCELECOXIB USP

DMF 275012013

TIANJIN TIANYAO PHARMACEUTICALS CO LTDCELECOXIB USP

DMF 276352015

SOLARA ACTIVE PHARMA SCIENCES LTDCELECOXIB USP

DMF 280202014

SCINOPHARM TAIWAN LTDCELECOXIB USP

DMF 309262016

ZHEJIANG YONGTAI PHARMACEUTICAL CO LTDCELECOXIB, USP

DMF 311012016

HIKAL LTDCELECOXIB

DMF 319712017

UNICHEM LABORATORIES LTDCELECOXIB USP

DMF 335792019

AURORE LIFE SCIENCES PRIVATE LTDCELECOXIB USP

DMF 340702019

HENAN DONGTAI PHARM CO LTDCELECOXIB

DMF 370922022

MICRO LABS LTDCELECOXIB USP (PROCESS-II)

DMF 372902022

CHEMECA DRUGS PRIVATE LTDCELECOXIB USP

DMF 375302023

NANO SYSTEMSInactiveCELECOXIB 200 MG FILM COATED TABLETS

DMF 149292000

ERREGIERRE SPAInactiveCELECOXIB USP-EP

DMF 196522006

HISUN PHARMACEUTICAL NANTONG CO LTDInactiveCELECOXIB USP

DMF 277442013

WATERSTONE PHARMACEUTICALS (HUBEI) CO LTDInactiveCELECOXIB

DMF 278722013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Jun 11, 2015	ORIG -1	View Letter (PDF)
Apr 10, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Oct 29, 2014

No patent or exclusivity listings for this strength.

#002 — 100MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jun 9, 2015

#003 — 200MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jun 9, 2015

#004 — 400MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jun 9, 2015